Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders
暂无分享,去创建一个
Enrico Fainardi | E. Granieri | E. Fainardi | M. Castellazzi | Carlo Contini | Rosario Cultrera | Silva Seraceni | Enrico Granieri | Massimiliano Castellazzi | C. Contini | S. Seraceni | R. Cultrera
[1] S. A. Cann,et al. Chlamydia, Rickettsia, and antibiotic treatment of multiple sclerosis. , 2000 .
[2] Yoshimasa Yamamoto,et al. PCR-Based Method for Isolation and Detection of Chlamydia pneumoniae DNA in Cerebrospinal Fluids , 2001, Clinical Diagnostic Laboratory Immunology.
[3] A. Lumsden,et al. Chlamydia pneumoniae and vascular disease: an update. , 2006, Journal of vascular surgery.
[4] T. Christensen,et al. The role of EBV in MS pathogenesis. , 2006, International MS journal.
[5] Rob Nicolson,et al. Genetic and Neurodevelopmental Influences in Autistic Disorder , 2003, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[6] G. Wilcock,et al. Absence of Chlamydia pneumoniae in brain of vascular dementia patients , 2003, Neurobiology of Aging.
[7] S. Robinson,et al. Challenges and directions for the pathogen hypothesis of Alzheimer’s disease , 2004, Neurobiology of Aging.
[8] S. Homma,et al. Seropositivity to Chlamydia pneumoniae Is Associated With Risk of First Ischemic Stroke , 2006, Stroke.
[9] Michael Borrie,et al. A Randomized, Controlled Trial of Doxycycline and Rifampin for Patients with Alzheimer's Disease , 2004, Journal of the American Geriatrics Society.
[10] G. Nicolson. Chronic Bacterial and Viral Infections in Neurodegenerative and Neurobehavioral Diseases , 2008, Laboratory Medicine.
[11] G. Wilcock,et al. Failure to correlate C. pneumoniae with late onset Alzheimer's disease. , 2002, Neurology.
[12] A. Gebert,et al. First-Choice Antibiotics at Subinhibitory Concentrations Induce Persistence of Chlamydia pneumoniae , 2004, Antimicrobial Agents and Chemotherapy.
[13] D. Bennett,et al. Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. , 2003, Archives of neurology.
[14] E. Granieri,et al. Chlamydophila pneumoniae DNA and mRNA transcript levels in peripheral blood mononuclear cells and cerebrospinal fluid of patients with multiple sclerosis , 2008, Neuroscience Research.
[15] C. Stratton,et al. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis , 1999, Annals of neurology.
[16] F. Blasi,et al. Reliability of Nested PCR for Detection of Chlamydia pneumoniae DNA in Atheromas: Results from a Multicenter Study Applying Standardized Protocols , 2002, Journal of Clinical Microbiology.
[17] S. Menzo,et al. Lack of Chlamydia infection of the central nervous system in multiple sclerosis , 2000, Annals of neurology.
[18] E. Granieri,et al. Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis , 2004, Multiple sclerosis.
[19] Enrico Fainardi,et al. Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms , 2004, Journal of the Neurological Sciences.
[20] A. Grau,et al. Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis , 2000, Annals of neurology.
[21] H. Gérard,et al. Frequency of apolipoprotein E (APOE) allele types in patients with Chlamydia-associated arthritis and other arthritides. , 1999, Microbial pathogenesis.
[22] A. Frydén,et al. A clinical and epidemiological study of "ornithosis" caused by Chlamydia psittaci and Chlamydia pneumoniae (strain TWAR). , 1989, Scandinavian journal of infectious diseases.
[23] C. Stratton,et al. Pilot study to examine the effect of antibiotic therapy on MRI outcomes in RRMS , 2005, Journal of the Neurological Sciences.
[24] A. Ascherio,et al. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. , 2006, Archives of neurology.
[25] E. Renvoize,et al. A sero-epidemiological study of conventional infectious agents in Alzheimer's disease. , 1987, Age and ageing.
[26] G. Cutter,et al. Infectious causes of multiple sclerosis , 2006, The Lancet Neurology.
[27] D. Thornton. A survey of mycoplasma detection in veterinary vaccines. , 1986, Vaccine.
[28] M. Freedman,et al. Cerebrospinal fluid analysis in the diagnosis of multiple sclerosis. , 2006, Advances in neurology.
[29] R Brookmeyer,et al. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. , 1998, American journal of public health.
[30] L. Campbell,et al. Chlamydia pneumoniae — an infectious risk factor for atherosclerosis? , 2004, Nature Reviews Microbiology.
[31] F. Hanefeld,et al. Chlamydia pneumoniae in children with MS , 2003, Neurology.
[32] E. Granieri,et al. Molecular detection of Parachlamydia-like organisms in cerebrospinal fluid of patients with multiple sclerosis , 2008, Multiple sclerosis.
[33] G. Schiavoni,et al. Chlamydia pneumoniae DNA in patients with symptomatic carotid atherosclerotic disease. , 2003, Journal of vascular surgery.
[34] C. Stratton,et al. Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS , 1998, Neurology.
[35] R. Ravid,et al. Broad Expression of Toll‐Like Receptors in the Human Central Nervous System , 2002, Journal of neuropathology and experimental neurology.
[36] D. Appelt,et al. Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells , 2003, Journal of neuroscience research.
[37] M. Wozniak,et al. Association of HSV1 and apolipoprotein E-ε4 in Alzheimer’s disease , 2011, Journal of NeuroVirology.
[38] S. Ward,et al. Autistic Spectrum Disorder , 2004, Autism : the international journal of research and practice.
[39] E. B. Paniagua,et al. Association between seropositivity to Chlamydia pneumoniae and acute ischaemic stroke , 2002, European journal of neurology.
[40] I. Wirguin,et al. Infection and the etiology and pathogenesis of multiple sclerosis , 2001, Current neurology and neuroscience reports.
[41] G. Tositti,et al. Chlamydia pneumoniae infection in HIV‐positive patients: prevalence and relationship with lipid profile , 2005, HIV medicine.
[42] L. Defebvre,et al. Méningoencéphalite à Chlamydiae pneumoniae , 2005 .
[43] W. Hop,et al. Chlamydia pneumoniae and the risk for exacerbation in multiple sclerosis patients , 2003, Annals of neurology.
[44] C. Stratton,et al. Antimicrobial Treatment of Multiple Sclerosis , 2007, Infection.
[45] E. Granieri,et al. Molecular identification and antibody testing of Chlamydophila pneumoniae in a subgroup of patients with HIV-associated dementia complex. Preliminary results , 2003, Journal of Neuroimmunology.
[46] R. Kronmal,et al. Azithromycin for the secondary prevention of coronary events. , 2005, The New England journal of medicine.
[47] S. Patten,et al. Minocycline reduces gadolinium‐enhancing magnetic resonance imaging lesions in multiple sclerosis , 2004, Annals of neurology.
[48] C. Pozzilli,et al. Real time PCR for detection of Chlamydophila pneumoniae in peripheral blood mononuclear cells of patients with multiple sclerosis , 2007, Journal of Neurology.
[49] Song-Yi Yao,et al. Detection of chlamydial bodies and antigens in the central nervous system of patients with multiple sclerosis. , 2005, The Journal of infectious diseases.
[50] P. Apfalter. Chlamydia pneumoniae, stroke, and serological associations: anything learned from the atherosclerosis-cardiovascular literature or do we have to start over again? , 2006, Stroke.
[51] B. Horne,et al. Serum Immunoglobulin G Antibodies to Chlamydial Heat Shock Protein 60 but Not to Human and Bacterial Homologs Are Associated With Coronary Artery Disease , 2002, Circulation.
[52] C. Stratton,et al. Association of Chlamydia pneumoniae with central nervous system disease. , 2003, Microbes and infection.
[53] J. Mezzadri,et al. Postoperative fourth ventricle tension pneumocephalus. , 1992, Journal of Neurology Neurosurgery & Psychiatry.
[54] T. Matsuishi,et al. Possible Association Between Congenital Cytomegalovirus Infection and Autistic Disorder , 2003, Journal of autism and developmental disorders.
[55] J. Turnidge,et al. Neurological complications of chlamydial infections: case report and review. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[56] L. Jackson,et al. Chlamydia pneumoniae (TWAR) , 1995, Clinical microbiology reviews.
[57] Q Hao,et al. Chlamydia pneumoniae infection associated with enhanced MRI spinal lesions in multiple sclerosis , 2002, Multiple sclerosis.
[58] C. Stratton,et al. Comparative Study of the Presence of Chlamydia pneumoniae in Cerebrospinal Fluid of Patients with Clinically Definite and Monosymptomatic Multiple Sclerosis , 2002, Clinical and Vaccine Immunology.
[59] J. Miklossy,et al. Alzheimer's disease—a spirochetosis? , 1993, Neuroreport.
[60] J. Bajramovic,et al. Mistaken self, a novel model that links microbial infections with myelin-directed autoimmunity in multiple sclerosis , 2000, Journal of Neuroimmunology.
[61] S. Reingold,et al. Revised estimate of the prevalence of multiple sclerosis in the united states , 1992, Annals of neurology.
[62] P. Mirandola,et al. Human herpesvirus 6: An emerging pathogen. , 1999, Emerging infectious diseases.
[63] D. Appelt,et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain , 1998, Medical Microbiology and Immunology.
[64] M. Barnett,et al. The pathology of multiple sclerosis: a paradigm shift , 2006, Current opinion in neurology.
[65] L. Airas,et al. Encephalitis associated with Chlamydia pneumoniae , 2001, Neurology.
[66] J. Jakobsen,et al. Presence of Epstein–Barr virus and human herpesvirus 6B DNA in multiple sclerosis patients: associations with disease activity , 2005, Acta neurologica Scandinavica.
[67] C. Contini. International conference on chlamydial and Mycoplasma human infections. , 2007, Future microbiology.
[68] E. Cook,et al. Genetics of childhood disorders: XLVI. Autism, part 5: genetics of autism. , 2003, Journal of the American Academy of Child and Adolescent Psychiatry.
[69] P. Doraiswamy,et al. Current Status of Metals as Therapeutic Targets in Alzheimer's Disease , 2003, Journal of the American Geriatrics Society.
[70] J. Ager,et al. The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype. , 2005, Microbial pathogenesis.
[71] J. R. Smith,et al. Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS , 2000, Neurology.
[72] E. Mariani,et al. Incidence and etiology of dementia in a large elderly Italian population , 2005, Neurology.
[73] B. Guidet,et al. Severe meningoencephalitis: an unusual manifestation of Chlamydia pneumoniae infection. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[74] P. Saikku,et al. Association of chlamydial infection with cerebrovascular disease. , 1996, Stroke.
[75] R. Peeling,et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[76] S. Sriram,et al. Chlamydia pneumoniae infection of the central nervous system , 2001, Current opinion in neurology.
[77] R. Ring,et al. Failure To Detect Chlamydia pneumoniaein the Late-Onset Alzheimer's Brain , 2000, Journal of Clinical Microbiology.
[78] R. Keefover. The clinical epidemiology of Alzheimer's disease. , 1996, Neurologic clinics.
[79] B. Pogo,et al. A study of viral genomes and antigens in brains of patients with Alzheimer's disease. , 1987, Brain : a journal of neurology.
[80] G. Comi,et al. An MRI study of Chlamydia pneumoniae infection in Italian multiple sclerosis patients , 2003, Multiple sclerosis.
[81] A. Grau,et al. Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis , 2004, Journal of Neurology.
[82] M. Nieminen,et al. SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION , 1988, The Lancet.
[83] DH Gilden,et al. The search for virus in multiple sclerosis brain , 1996, Multiple sclerosis.
[84] B. Coombes,et al. Analytical Sensitivity, Reproducibility of Results, and Clinical Performance of Five PCR Assays for Detecting Chlamydia pneumoniae DNA in Peripheral Blood Mononuclear Cells , 2000, Journal of Clinical Microbiology.
[85] D. Keše,et al. Chlamydia pneumonia and meningoencephalitis. , 1994, The New England journal of medicine.
[86] M. Nieminen,et al. Chlamydia pneumoniae DNA is present in peripheral blood mononuclear cells during acute coronary syndrome and correlates with chlamydial lipopolysaccharide levels in serum , 2009, Scandinavian journal of infectious diseases.
[87] R Brookmeyer,et al. Age-specific incidence rates of Alzheimer’s disease , 2000, Neurology.
[88] P. Bagos,et al. Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis , 2006, Multiple sclerosis.
[89] L. Lue,et al. Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. , 1996, Journal of neuropathology and experimental neurology.
[90] Yoshimasa Yamamoto. PCR in Diagnosis of Infection: Detection of Bacteria in Cerebrospinal Fluids , 2002, Clinical and Vaccine Immunology.
[91] C. Wolfson,et al. Human herpes virus 6 and multiple sclerosis , 2002, Acta neurologica Scandinavica.
[92] M. Hammerschlag,et al. Is Chlamydia pneumoniae Present in Brain Lesions of Patients with Multiple Sclerosis? , 2000, Journal of Clinical Microbiology.
[93] E. Skriver,et al. Chlamydia pneumoniae‐associated ADEM , 2000, European journal of neurology.
[94] P. Heuschmann,et al. Association Between Infection With Helicobacter pylori and Chlamydia pneumoniae and Risk of Ischemic Stroke Subtypes: Results From a Population-Based Case-Control Study , 2001, Stroke.
[95] D. Appelt,et al. Chlamydia pneumoniae infection alters the junctional complex proteins of human brain microvascular endothelial cells. , 2002, FEMS microbiology letters.
[96] M. Leinonen,et al. Evidence for infectious agents in cardiovascular disease and atherosclerosis. , 2002, The Lancet. Infectious diseases.
[97] D. Gilden,et al. Comparison of immunoglobulin G heavy-chain sequences in MS and SSPE brains reveals an antigen-driven response , 2000, Neurology.
[98] M. Thornquist,et al. Interlaboratory Reliability of Microimmunofluorescence Test for Measurement of Chlamydia pneumoniae-Specific Immunoglobulin A and G Antibody Titers , 2004 .
[99] M. Hammerschlag,et al. Chlamydia pneumoniae and Atherosclerosis: Critical Assessment of Diagnostic Methods and Relevance to Treatment Studies , 2002, Clinical Microbiology Reviews.
[100] R. Peeling,et al. A prospective study of Chlamydia pneumoniae infection and risk of MS in two US cohorts , 2004, Neurology.
[101] D. Gilden. Chlamydia: A role for multiple sclerosis or more confusion? , 1999, Annals of neurology.
[102] P. Saikku,et al. Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland. , 1988, The Journal of infectious diseases.
[103] J. Picazo,et al. Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection. , 2004, Archives of neurology.
[104] Indrawati,et al. Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage-lipoprotein interactions. , 2000, The Journal of infectious diseases.
[105] H. Katus,et al. Chlamydia pneumoniae Infection in Circulating Human Monocytes Is Refractory to Antibiotic Treatment , 2001, Circulation.
[106] S. Wang,et al. Outbreak ofChlamydia pneumoniae infection in four farm families , 1992, European Journal of Clinical Microbiology and Infectious Diseases.
[107] R. Sacco,et al. Chlamydia pneumoniae and the risk of first ischemic stroke : The Northern Manhattan Stroke Study. , 2000, Stroke.
[108] C. Stratton,et al. Multiple sclerosis: an infectious syndrome involving Chlamydophila pneumoniae. , 2006, Trends in microbiology.
[109] R. Wank,et al. High risk of schizophrenia and other mental disorders associated with chlamydial infections: hypothesis to combine drug treatment and adoptive immunotherapy. , 2005, Medical hypotheses.
[110] S. Gartner. HIV Infection and Dementia , 2000, Science.
[111] Domenico Inzitari,et al. Incidence of Dementia, Alzheimer's Disease, and Vascular Dementia in Italy. The ILSA Study , 2002, Journal of the American Geriatrics Society.
[112] C. Gaydos,et al. Is Chlamydia pneumoniae found in spinal fluid samples from multiple sclerosis patients? Conflicting results , 2002, Multiple sclerosis.
[113] E. Cho,et al. Continual Breakdown and Regeneration of Myelin in Progressive Multiple Sclerosis Plaques a , 1984, Annals of the New York Academy of Sciences.
[114] M. Nieminen,et al. Association of Chlamydia pneumoniae Infection with HLA-B*35 in Patients with Coronary Artery Disease , 2007, Clinical and Vaccine Immunology.
[115] C. Andrzejewski,et al. Detection of Chlamydia in the peripheral blood cells of normal donors using in vitro culture, immunofluorescence microscopy and flow cytometry techniques , 2006, BMC infectious diseases.
[116] R. Bergamaschi,et al. Analysis of Chlamydia pneumoniae‐specific oligoclonal bands in multiple sclerosis and other neurologic diseases , 2005, Acta neurologica Scandinavica.
[117] Chlamydia pneumoniae infection in young stroke patients: a case–control study , 2004, European journal of neurology.
[118] D. Nochlin,et al. Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimer’s disease , 1999, Neurology.
[119] F. Hanefeld,et al. Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis , 2001, Annals of neurology.
[120] E. Granieri,et al. Under the microscope: focus on Chlamydia pneumoniae infection and multiple sclerosis. , 2008, Current neurovascular research.
[121] G. Wilcock,et al. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease , 1997, The Lancet.
[122] C. Stratton,et al. Qualitative and Quantitative Detection of Chlamydophila pneumoniae DNA in Cerebrospinal Fluid from Multiple Sclerosis Patients and Controls , 2009, PloS one.
[123] S. Shimohama,et al. Coexistence of expanded CAG repeats in the MJD1a and DRPLA genes , 2000, Neurology.
[124] D. Michel,et al. Lumbosacral meningoradiculitis associated with Chlamydia pneumoniae infection. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[125] H. Gérard,et al. Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brain. , 2009, International journal of medical microbiology : IJMM.
[126] B. Sundelöf,et al. An unusual manifestation of Chlamydia pneumoniae infection: meningitis, hepatitis, iritis and atypical erythema nodosum. , 1993, Scandinavian journal of infectious diseases.
[127] D. Ojcius,et al. Chlamydia and apoptosis: life and death decisions of an intracellular pathogen , 2004, Nature Reviews Microbiology.
[128] F. Budak,et al. THE INVESTIGATION OF Chlamydophila pneumoniae IN PATIENTS WITH MULTIPLE SCLEROSIS , 2007, The International journal of neuroscience.
[129] Lisa Chasan-Taber,et al. Infection with Chlamydia pneumoniae and Risk of Multiple Sclerosis , 2003, Epidemiology.
[130] W. Matthews,et al. UNCONVENTIONAL VIRUS INFECTION AND NEUROLOGICAL DISEASE , 1986, Neuropathology and applied neurobiology.
[131] S. Folstein,et al. Genetics of austim: complex aetiology for a heterogeneous disorder , 2001, Nature Reviews Genetics.
[132] G. Rosati,et al. Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis and neurological controls , 2001, Multiple sclerosis.
[133] G. Byrne. Chlamydia uncloaked , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[134] A. Dolei. MSRV/HERV-W/syncytin and its linkage to multiple sclerosis: The usablity and the hazard of a human endogenous retrovirus , 2005, Journal of NeuroVirology.
[135] S. Haidl,et al. Guillain-Barré syndrome after Chlamydia pneumoniae infection. , 1992, The New England journal of medicine.
[136] D. Appelt,et al. Role of infection in Alzheimer's disease , 2001, The Journal of the American Osteopathic Association.
[137] Elevated levels of anti‐Chlamydia pneumoniae IgA and IgG antibodies in young adults with ischemic stroke , 2007, Acta neurologica Scandinavica.
[138] D. Appelt,et al. Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice , 2004, Neurobiology of Aging.
[139] N. Quinn,et al. A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism , 2000, Neurology.
[140] R. Friedland,et al. The viral hypothesis of Alzheimer's disease. Absence of antibodies to lentiviruses. , 1990, Archives of neurology.
[141] R. Monno,et al. Role of chlamydia infection in the pathogenesis of atherosclerotic plaques in HIV-1-positive patients. , 2006, In vivo.
[142] S. Söderberg,et al. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. , 1998, The Journal of infectious diseases.
[143] T. Derfuss,et al. Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response. , 2001, Brain : a journal of neurology.
[144] W. Solbach,et al. Failure To Detect Chlamydia pneumoniaein Brain Sections of Alzheimer's Disease Patients , 2000, Journal of Clinical Microbiology.
[145] N. Losseff,et al. Chlamydophila pneumoniae infection of the central nervous system in patients with multiple sclerosis. , 2004, Journal of neurology, neurosurgery, and psychiatry.
[146] J. Chia,et al. Chronic Chlamydia pneumoniae infection: a treatable cause of chronic fatigue syndrome. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[147] W. McMahon,et al. Autistic disorder and viral infections , 2005, Journal of NeuroVirology.
[148] M. Leinonen,et al. Autoimmunity to Human Heat Shock Protein 60, Chlamydia pneumoniae Infection, and Inflammation in Predicting Coronary Risk , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[149] G. Nicolson,et al. Multiple co‐infections (Mycoplasma, Chlamydia, human herpes virus‐6) in blood of chronic fatigue syndrome patients: association with signs and symptoms , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[150] N. Okabe,et al. Autism and infection/immunization episodes in Japan. , 2001, Japanese journal of infectious diseases.
[151] M. Ieven,et al. Involvement of Chlamydia pneumoniae in Atherosclerosis: More Evidence for Lack of Evidence , 2005, Journal of Clinical Microbiology.
[152] R. Peeling,et al. Chlamydial heat-shock protein-60 antibody and correlation with Chlamydia pneumoniae in atherosclerotic plaques. , 2002, The Journal of infectious diseases.
[153] Xi Yang,et al. Role of toll-like receptors in immune responses to chlamydial infections. , 2008, Current pharmaceutical design.
[154] K. Büssow,et al. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. , 2005, The Journal of clinical investigation.
[155] E. Antón,et al. Meningoencephalitis and Chlamydia pneumoniae infection , 2000, European journal of neurology.
[156] P. Visca,et al. Antibodies to 60-Kilodalton Heat Shock Protein and Outer Membrane Protein 2 of Chlamydia pneumoniae in Patients with Coronary Heart Disease , 2002, Clinical and Vaccine Immunology.
[157] D. Coomans,et al. High prevalence of Mycoplasma infections among European chronic fatigue syndrome patients. Examination of four Mycoplasma species in blood of chronic fatigue syndrome patients. , 2002, FEMS immunology and medical microbiology.
[158] H. Gérard,et al. Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain. , 2006, FEMS immunology and medical microbiology.
[159] E. Herrgård,et al. Epidemiology of encephalitis in children. A prospective multicentre study , 1997, European Journal of Pediatrics.
[160] L. Cahoon. The curious case of clioquinol , 2009, Nature Medicine.
[161] C. Polman,et al. Is Chlamydia pneumoniae present in the central nervous system of multiple sclerosis patients? , 2000, Annals of neurology.
[162] A. Berghold,et al. Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker , 2001, Multiple sclerosis.
[163] S. Leekam,et al. The Diagnostic Interview for Social and Communication Disorders: background, inter-rater reliability and clinical use. , 2002, Journal of child psychology and psychiatry, and allied disciplines.
[164] P. Roholl,et al. Distribution of Chlamydia pneumoniae in the Human Arterial System and Its Relation to the Local Amount of Atherosclerosis Within the Individual , 2001, Circulation.
[165] R. Peeling,et al. Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results. , 2000, The Journal of infectious diseases.